» Articles » PMID: 32820163

Comorbid Depression in Medical Diseases

Overview
Specialty General Medicine
Date 2020 Aug 22
PMID 32820163
Citations 171
Authors
Affiliations
Soon will be listed here.
Abstract

Depression is one of the most common comorbidities of many chronic medical diseases including cancer and cardiovascular, metabolic, inflammatory and neurological disorders. Indeed, the prevalence of depression in these patient groups is often substantially higher than in the general population, and depression accounts for a substantial part of the psychosocial burden of these disorders. Many factors can contribute to the occurrence of comorbid depression, such as shared genetic factors, converging biological pathways, social factors, health behaviours and psychological factors. Diagnosis of depression in patients with a medical disorder can be particularly challenging owing to symptomatic overlap. Although pharmacological and psychological treatments can be effective, adjustments may need to be made for patients with a comorbid medical disorder. In addition, symptoms or treatments of medical disorders may interfere with the treatment of depression. Conversely, symptoms of depression may decrease adherence to treatment of both disorders. Thus, comprehensive treatment plans are necessary to optimize care.

Citing Articles

Application of Near-Infrared Spectroscopy in Early Detection of Antidepressant Treatment Efficacy in Major Depressive Disorder: A Longitudinal Study.

Huang J, Shan J Actas Esp Psiquiatr. 2025; 53(2):275-283.

PMID: 40071372 PMC: 11898260. DOI: 10.62641/aep.v53i2.1708.


Association between chronic diseases and depressive inclinations among rural middle-aged and older adults.

Xiang L, Yang J, Yamada M, Shi Y, Nie H Sci Rep. 2025; 15(1):7784.

PMID: 40044777 PMC: 11882913. DOI: 10.1038/s41598-025-91679-5.


Lifestyle behaviours do not moderate the association between childhood maltreatment and comorbid depression and cardiometabolic disease in older adults: a meta-analysis.

Layinka O, Souama C, Defina S, Baltramonaityte V, Cecil C, Shah P BMC Med. 2025; 23(1):133.

PMID: 40038665 PMC: 11881505. DOI: 10.1186/s12916-025-03950-1.


Explainable Artificial Intelligence Models for Predicting Depression Based on Polysomnographic Phenotypes.

Enkhbayar D, Ko J, Oh S, Ferdushi R, Kim J, Key J Bioengineering (Basel). 2025; 12(2).

PMID: 40001705 PMC: 11851660. DOI: 10.3390/bioengineering12020186.


Associations between plasma proteins and psychological wellbeing: evidence from over 20 years of the English Longitudinal Study of Ageing.

Gong J, Scholes S, Cole S, Zaninotto P, Steptoe A medRxiv. 2025; .

PMID: 39974132 PMC: 11838684. DOI: 10.1101/2025.02.05.25321715.


References
1.
Otte C, Gold S, Penninx B, Pariante C, Etkin A, Fava M . Major depressive disorder. Nat Rev Dis Primers. 2016; 2:16065. DOI: 10.1038/nrdp.2016.65. View

2.
Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B . Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007; 370(9590):851-8. DOI: 10.1016/S0140-6736(07)61415-9. View

3.
Puyat J, Kazanjian A, Wong H, Goldner E . Comorbid Chronic General Health Conditions and Depression Care: A Population-Based Analysis. Psychiatr Serv. 2017; 68(9):907-915. DOI: 10.1176/appi.ps.201600309. View

4.
Gonzalez J, Peyrot M, McCarl L, Collins E, Serpa L, Mimiaga M . Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008; 31(12):2398-403. PMC: 2584202. DOI: 10.2337/dc08-1341. View

5.
Pelletier G, Verhoef M, Khatri N, Hagen N . Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol. 2002; 57(1):41-9. DOI: 10.1023/a:1015728825642. View